Lcnb Corp Abbott Laboratories Transaction History

Lcnb Corp

$280 Million
Q2 2025

A detailed history of Lcnb Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Lcnb Corp holds 15,887 shares of ABT stock, worth $2.14 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

15,887

Previous 15,917 0.19%

Holding current value

$2.14 Million

Previous $2.11 Million 2.32%

% of portfolio

0.77%

Previous 0.79%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$123.95 - $138.08 $3,718 - $4,142	-30 Reduced 0.19%	15,887 $2.16 Million
Q1 2025 May 12, 2025	BUY	$111.1 - $140.22 $8,888 - $11,217	80 Added 0.51%	15,917 $2.11 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $15,109 - $16,866	-150 Reduced 0.94%	15,837 $1.65 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $2,957 - $3,265	27 Added 0.17%	15,987 $1.82 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $721 - $883	8 Added 0.05%	15,960 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $95,530 - $114,620	-1,000 Reduced 5.9%	15,952 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $24,287 - $27,061	241 Added 1.44%	16,952 $1.85 Million
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $42,618 - $50,164	-440 Reduced 2.57%	16,711 $1.69 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $38,024 - $44,608	400 Added 2.39%	17,151 $1.88 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $20,803 - $24,086	-215 Reduced 1.27%	16,751 $1.62 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $102,172 - $123,493	-1,001 Reduced 5.57%	16,966 $1.84 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $100,337 - $122,355	880 Added 5.15%	17,967 $2.13 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $35,352 - $43,286	-306 Reduced 1.76%	17,087 $2.41 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $26,948 - $29,812	-231 Reduced 1.31%	17,393 $2.06 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $21,158 - $24,906	200 Added 1.15%	17,624 $2.04 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $13,060 - $15,387	-120 Reduced 0.68%	17,424 $2.09 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $49,350 - $53,777	-470 Reduced 2.61%	17,544 $1.92 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $22,910 - $27,822	-250 Reduced 1.37%	18,014 $1.96 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $15,313 - $19,600	-200 Reduced 1.08%	18,264 $1.67 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $17,275 - $25,261	-275 Reduced 1.47%	18,464 $1.46 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $54,957 - $61,180	-700 Reduced 3.6%	18,739 $1.63 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $23,733 - $25,734	290 Added 1.51%	19,439 $1.63 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $8,891 - $10,370	-122 Reduced 0.63%	19,149 $1.61 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $104,031 - $125,774	-1,571 Reduced 7.54%	19,271 $1.54 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $34,661 - $41,815	-570 Reduced 2.66%	20,842 $1.53 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $47,725 - $52,674	829 Added 4.03%	21,412 $1.31 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $23,464 - $26,529	-417 Reduced 1.99%	20,583 $1.23 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $20,398 - $21,838	-380 Reduced 1.78%	21,000 $1.2 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $12,591 - $14,053	-262 Reduced 1.21%	21,380 $1.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,642	21,642 $1.05 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account